NO140300C - Analogifremgangsmaate for fremstilling av terapeutisk aktive (omega-1)-oksodialkylxantiner - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive (omega-1)-oksodialkylxantiner

Info

Publication number
NO140300C
NO140300C NO742121A NO742121A NO140300C NO 140300 C NO140300 C NO 140300C NO 742121 A NO742121 A NO 742121A NO 742121 A NO742121 A NO 742121A NO 140300 C NO140300 C NO 140300C
Authority
NO
Norway
Prior art keywords
oxodial
kylxantines
omega
preparation
therapeutic active
Prior art date
Application number
NO742121A
Other languages
English (en)
Norwegian (no)
Other versions
NO140300B (no
NO742121L (sv
Inventor
Werner Mohler
Manfred Jayme
Jaromir Komarek
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO742121L publication Critical patent/NO742121L/no
Publication of NO140300B publication Critical patent/NO140300B/no
Publication of NO140300C publication Critical patent/NO140300C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
NO742121A 1973-06-16 1974-06-11 Analogifremgangsmaate for fremstilling av terapeutisk aktive (omega-1)-oksodialkylxantiner NO140300C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2330742A DE2330742C2 (de) 1973-06-16 1973-06-16 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel

Publications (3)

Publication Number Publication Date
NO742121L NO742121L (sv) 1975-01-13
NO140300B NO140300B (no) 1979-04-30
NO140300C true NO140300C (no) 1979-08-08

Family

ID=5884209

Family Applications (1)

Application Number Title Priority Date Filing Date
NO742121A NO140300C (no) 1973-06-16 1974-06-11 Analogifremgangsmaate for fremstilling av terapeutisk aktive (omega-1)-oksodialkylxantiner

Country Status (17)

Country Link
US (1) US4289776A (sv)
JP (1) JPS5233120B2 (sv)
AR (3) AR208179A1 (sv)
AT (1) AT334388B (sv)
BE (1) BE816332A (sv)
CH (2) CH612969A5 (sv)
DE (1) DE2330742C2 (sv)
DK (1) DK145676C (sv)
ES (1) ES427171A1 (sv)
FI (1) FI58920C (sv)
FR (1) FR2233065B1 (sv)
GB (1) GB1470220A (sv)
IE (1) IE39898B1 (sv)
NL (1) NL182806C (sv)
NO (1) NO140300C (sv)
SE (1) SE423631B (sv)
ZA (1) ZA743760B (sv)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH608236A5 (sv) * 1974-01-22 1978-12-29 Wuelfing J A Fa
DE2507555A1 (de) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
DE2507554A1 (de) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS54112893A (en) * 1978-02-21 1979-09-04 Kohjin Co Ltd Preparation of 1-(5'-oxohexyl)-3,7-diethylxanthine
DE2967632D1 (en) * 1978-04-22 1986-12-04 Beecham Wuelfing Gmbh & Co Kg Use of a xanthine derivate in the manufacture of a medicament
IL59665A0 (en) * 1979-04-05 1980-06-30 Wuelfing J Kg Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
EP0042706B1 (en) * 1980-06-21 1985-12-27 BEECHAM - WUELFING GmbH & Co. KG Xanthine derivatives, pharmaceutical compositions containing them and a process for their preparation
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
JPH062675B2 (ja) * 1985-04-05 1994-01-12 ヘキストジヤパン株式会社 記憶障害治療剤
GB8621869D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Treatment
JPS63225317A (ja) * 1986-10-06 1988-09-20 Hoechst Japan Kk 抗消化性潰瘍剤
IT1197516B (it) * 1986-12-24 1988-11-30 Abc Ist Biolog Chem Spa Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
US5096906A (en) * 1986-12-31 1992-03-17 University Of Virginia Alumni Patents Foundation Method of inhibiting the activity of leukocyte derived cytokines
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
CA2030112A1 (en) * 1989-11-24 1991-05-25 Yasuo Ito Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
DE3942872A1 (de) * 1989-12-23 1991-06-27 Hoechst Ag Verfahren zur enantioselektiven darstellung von ((omega)-1)-hydroxyalkylxanthinen
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
EP0514789B1 (de) * 1991-05-23 1996-09-11 Hoechst Aktiengesellschaft Die Verwendung von 1-(5-Oxohexyl)-3-methyl-7-n-propyl-xanthin in der Gefässchirurgie
MX9203323A (es) * 1991-07-11 1994-07-29 Hoechst Ag El empleo de derivados de xantina para el tratamiento de lesiones secundarias de las celulas nerviosas y trastornos funcionales despues de traumas craneo-cerebrales.
JP2549480B2 (ja) * 1991-12-10 1996-10-30 ヘキストジャパン株式会社 排尿障害改善剤
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US6020337A (en) * 1993-04-05 2000-02-01 Cell Therapeutics, Inc. Electronegative-substituted long chain xanthine compounds
US5670506A (en) * 1993-04-05 1997-09-23 Cell Therapeutics, Inc. Halogen, isothiocyanate or azide substituted xanthines
AU1868195A (en) * 1994-01-28 1995-08-15 Cell Therapeutics, Inc. Cell signaling inhibitors
US5762953A (en) * 1996-08-22 1998-06-09 Theratech, Inc. Transdermal propentofylline compositions for the treatment of Alzheimers disease
DE19707655A1 (de) * 1997-02-26 1998-08-27 Hoechst Ag Kombinationspräparat zur Anwendung bei Demenz
US20040110776A1 (en) * 2002-02-22 2004-06-10 Iok-Hou Pang Use of propentofylline to control intraocular pressure
JP5567503B2 (ja) 2008-02-29 2014-08-06 コンサート ファーマシューティカルズ インコーポレイテッド 置換キサンチン誘導体
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
US8952016B2 (en) 2009-02-27 2015-02-10 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
EP3397640B1 (en) * 2015-12-29 2021-08-04 INSERM - Institut National de la Santé et de la Recherche Médicale Xanthine derivative inhibitors of bet proteins
CN112724160A (zh) * 2021-03-19 2021-04-30 赤峰经方医药技术开发有限责任公司 一种己酮可可碱杂质的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH325292A (de) * 1953-10-21 1957-10-31 Geigy Ag J R Verfahren zur Herstellung von 7-Oxyalkyl-xanthinderivaten
FR1211333A (fr) * 1955-10-19 1960-03-15 Boehringer Sohn Ingelheim Perfectionnements apportés aux procédés pour fabriquer des oxyalcoylxanthines
DE1233405B (de) 1964-09-05 1967-02-02 Albert Ag Chem Werke Verfahren zur Herstellung von 7-(Oxoalkyl)-1, 3-dimethylxanthinen
US3737433A (en) 1964-09-05 1973-06-05 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines
US3422107A (en) 1964-09-05 1969-01-14 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines and a process for the preparation thereof
DE1545689C2 (de) 1964-09-05 1982-07-01 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von 2-Methyl-3-carbäthoxy-5,6-dihydropyran
US3864469A (en) * 1967-12-16 1975-02-04 Hoechst Ag Xanthines in pharmaceutical preparations and for stabilization of vitamins
DE1810705C3 (de) * 1968-11-25 1980-11-27 Hoechst Ag, 6000 Frankfurt Stabilisierung von Vitaminen
DE1911279A1 (de) * 1969-03-05 1970-11-12 Eckert Dr Theodor Verfahren zur Erhoehung der Resorptionsfaehigkeit von Arzneistoffen

Also Published As

Publication number Publication date
JPS5047992A (sv) 1975-04-28
ZA743760B (en) 1975-06-25
NL182806C (nl) 1988-05-16
NO140300B (no) 1979-04-30
AT334388B (de) 1976-01-10
ES427171A1 (es) 1976-07-16
FI58920B (fi) 1981-01-30
FI181974A (sv) 1974-12-17
NO742121L (sv) 1975-01-13
AR209320A1 (es) 1977-04-15
DE2330742C2 (de) 1982-07-29
FR2233065B1 (sv) 1978-07-21
BE816332A (fr) 1974-12-16
JPS5233120B2 (sv) 1977-08-26
AR208179A1 (es) 1976-12-09
DK145676C (da) 1983-08-01
CH608807A5 (sv) 1979-01-31
DK321574A (sv) 1975-02-10
IE39898B1 (en) 1979-01-31
NL7407890A (sv) 1974-12-18
AU7014774A (en) 1975-12-18
FI58920C (fi) 1981-05-11
NL182806B (nl) 1987-12-16
ATA491874A (de) 1976-05-15
AR209319A1 (es) 1977-04-15
SE423631B (sv) 1982-05-17
DE2330742A1 (de) 1975-01-09
IE39898L (en) 1974-12-16
FR2233065A1 (sv) 1975-01-10
US4289776A (en) 1981-09-15
SE7407913L (sv) 1974-12-17
CH612969A5 (sv) 1979-08-31
GB1470220A (en) 1977-04-14
DK145676B (da) 1983-01-24

Similar Documents

Publication Publication Date Title
NO140300C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (omega-1)-oksodialkylxantiner
NO140854C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptid-amider
NO137440C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pleuromutiliner
NO145382C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 3-amino-indazolkarboksylsyrederivater.
NO140381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner
NO141013C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive bifenylyl-derivater
NO145056C (no) (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
NO139685C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolin-derivater
NO140597C (no) Analogifremgangsmaate ved fremstillingen av terapeutisk aktive 8-azapurin-6-on-derivater
NO140671C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepiner
NO148375C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 3-klor-7-alfa-amino-acylcefalosporinforbindelser
NO140978C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO137899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider
NO140496C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
SE400551B (sv) Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat
NO140596C (no) Analogifremgangsmaate for fremstilling av en terapeutisk aktive hydroksyalkylxantiner
NO140012C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av naftyridin
NO139439C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive pyrazolon-(5)-forbindelser
NO138063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive normorfinon-derivater
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater
NO138250C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzylaminer
NO139735C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrimido(4,5-b)kinolin-4(3h)-on-derivater
NO145383C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte indoler.
NO140062C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminoderivater av pyrazolopyridin-ketoner